GLP-1 drugs found to lower cancer risk in diabetes patients

FHS
July 9, 2024
2:22 am

Research finds that GLP-1 receptor agonists significantly reduce the risk of 10 out of 13 obesity-associated cancers in type 2 diabetes patients compared to insulins, but show varied results against metformin.

Researchers develop bilayer adhesive hemostat using proteins derived from mussels and silkworms

In recent news, there has been a case where a patient experienced pain due to a surgical procedure involving sutures, resulting in the unintended presence

February 23, 2024

Covid-19 vaccine granted EUA by China

The vaccine demonstrated an excellent safety profile and 93.28% protective efficacy 14 days after injection. Credit: WestVac BioPharma Co., Ltd./ CNW. WestVac Biopharma has announced

June 9, 2023

FDA to expand total product life cycle program

Dive Brief: The Food and Drug Administration will expand its total product life cycle advisory program (TAP), the agency said Monday. Officials plan to start

July 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.